6.890USD+1.32%Mkt Cap: 85.33M USDP/E: —Last update: 2026-06-11
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous …
Industry Peers
Biotechnology112.95BUSDP/E 26.4
99.40BDKKP/E 19.0
64.11BUSDP/E 14.9
52.33BEURP/E 34.3
48.73BEURP/E 40.1
38.64BUSDP/E 72.5
32.08BSEKP/E 47.5
31.84BUSDP/E 29.1
Indicators:|
Key Statistics
Company
Market Cap85.33M USD
Enterprise Value77.49M USD
Revenue (TTM)4.28M USD
Gross Profit3.01M USD
Net Income (TTM)-7.80M USD
Revenue/Share0.4300 USD
Last Price6.890 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees24
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-114.83
PEG—
EV/EBITDA-10.77
EV/Revenue18.10
P/S19.93
P/B13.73
EPS (TTM)-0.80
EPS (Forward)-0.06
52W Range
2.19666% of range9.330
52W High9.330 USD
52W Low2.196 USD
Profitability
Gross Margin84.23%
Oper. Margin-108.26%
EBITDA Margin-168.04%
Profit Margin-218.55%
ROE-229.47%
ROA-121.81%
Growth
Revenue Growth79.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.43M USD
CapEx (TTM)131.15K USD
FCF Margin-84.30%
FCF Yield-4.23%
Net Debt-6.73M USD
Net Debt/EBITDA0.93
Balance Sheet
Debt/Equity0.12
Current Ratio2.89
Quick Ratio2.65
Book Value/Sh0.5020 USD
Cash/Share0.5720 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)11.00 USD
Target Range9.000 USD – 13.00 USD
# Analysts2
Ownership
Shares Out.12.38M
Float7.78M
Insiders21.43%
Institutions22.75%
Short Interest
Short Ratio3.1d
Short % Float5.39%
Short % Out.4.20%
Shares Short520.48K
Short (prev mo.)393.69K
Technical
SMA 507.487 (-8.0%)
SMA 2004.795 (+43.7%)
Beta1.41
S&P 52W Chg20.21%
Avg Vol (30d)161.17K
Avg Vol (10d)142.29K
Technical Indicators
RSI (14)43.3
MACD-0.2163
MACD Signal-0.1618
MACD Hist.-0.0545
BB Upper8.007 USD
BB Middle7.224 USD
BB Lower6.440 USD
BB Width21.68%
ATR (14)0.4855 USD
Vol Ratio (20d)1.16x